Nurses face a genuinely elevated cancer risk compared to the general population, and the reasons are rooted in specific, measurable workplace exposures rather than coincidence. A study of nurses at a tertiary university hospital in South Korea found their breast cancer incidence was 1.65 times higher than expected. For nurses who regularly handled chemotherapy drugs, that risk climbed to 2.73 times higher, and in certain oncology units it surged to nearly 13 times the general population rate.
Several occupational hazards converge in nursing: disrupted sleep cycles from night shifts, direct contact with cancer-causing drugs, exposure to radiation in procedural settings, and chronic psychological stress. Each of these has a distinct biological mechanism, and many nurses experience all of them simultaneously over careers spanning decades.
Night Shifts Disrupt a Key Cancer-Fighting Hormone
The International Agency for Research on Cancer classifies night shift work as “probably carcinogenic to humans,” based on evidence linking it to cancers of the breast, prostate, colon, and rectum. Nursing is one of the professions most heavily reliant on overnight schedules, with many nurses rotating through night shifts for years or even entire careers.
The core problem is artificial light at night. Your body produces melatonin, a hormone with strong anti-cancer properties, only in darkness. When you’re awake under bright hospital lights at 3 a.m., melatonin production drops significantly. This matters because melatonin does more than regulate sleep. It helps protect DNA from oxidative damage, influences estrogen signaling, and supports the immune system’s ability to detect and destroy abnormal cells. Animal studies show that light exposure at night increases oxidative DNA damage and accelerates tumor growth, effects that can be partially reversed when melatonin levels are restored.
The risk appears to increase with persistence. Studies suggest that long-duration or high-frequency night shift work is most strongly associated with breast cancer, though pinning down an exact threshold in years or shifts per month has been difficult. What’s clear is that the longer the circadian disruption continues, the more opportunity there is for cumulative biological damage.
Chemotherapy Drugs Don’t Stay in the IV Bag
Nurses who prepare and administer chemotherapy drugs absorb trace amounts through skin contact, inhalation of aerosolized particles, and accidental spills. The drugs most commonly involved in workplace spills include paclitaxel (about 20% of spills), gemcitabine (15%), and anthracyclines like doxorubicin (13%). Anthracyclines are classified as “probably carcinogenic” by the IARC and “reasonably anticipated to be carcinogenic” by the National Toxicology Program.
These are drugs specifically designed to damage DNA and kill rapidly dividing cells. In patients, that’s the point. In nurses, even tiny repeated exposures can accumulate over years. The South Korean hospital study found that nurses who had ever worked in departments handling these drugs had a breast cancer risk 3.39 times higher than the general population. A sensitivity analysis of nurses who previously worked in those settings but had since moved to other departments still showed an 8.54-fold increase, suggesting the damage from past exposure persists long after the contact ends.
The most striking finding came from nurses at the Oncology Daycare Center and cancer treatment units, where concentrated drug handling was routine. Their breast cancer risk reached 12.9 times the expected rate. While safety protocols like closed-system transfer devices and protective gowns reduce exposure, they don’t eliminate it entirely, and compliance varies across institutions.
Radiation Exposure in Procedural Settings
Nurses who assist with fluoroscopy-guided procedures, common in cardiac catheterization labs and interventional radiology suites, receive small but repeated doses of ionizing radiation. The annual effective dose for nurses in these settings typically ranges from about 0.5 to 4 millisieverts (mSv), depending on caseload and protective measures. For context, the general public’s recommended annual limit from occupational sources is 1 mSv, while the occupational limit for healthcare workers is 20 mSv.
Most nurses working in these environments stay well below the occupational ceiling, but the eye lens is a particular concern. One study found that scout nurses in cardiac catheterization labs could accumulate 39 mSv of eye exposure per year, nearly double the recommended limit of 20 mSv. Practical education on positioning and shielding has been shown to cut annual doses dramatically, from 1.33 mSv down to 0.47 mSv in one study. Still, the cumulative nature of radiation exposure means even modest annual doses add up across a 30-year career, and the cancer risk from ionizing radiation has no true “safe” threshold.
Chronic Stress Weakens Cancer Surveillance
Nursing consistently ranks among the most stressful professions, with long hours, emotional labor, staffing shortages, and life-or-death responsibility. This isn’t just an emotional burden. Chronic stress elevates glucocorticoids (stress hormones like cortisol), which directly interfere with the immune system’s ability to find and kill cancer cells.
Natural killer cells are one of the body’s primary defenses against emerging tumors. They patrol the body and destroy abnormal cells before they can establish themselves. Under chronic stress, these cells become measurably less effective. Research in breast cancer patients has shown that higher stress levels correlate with decreased production of key immune signaling molecules and impaired natural killer cell activity. In ovarian cancer patients, depression suppressed the cancer-killing ability of both natural killer cells and other tumor-infiltrating immune cells, though social support partially offset this effect.
Stress also promotes a molecular trick that tumors use to hide from the immune system. In animal models of liver cancer, depression-level stress hormones caused natural killer cells to produce more of a surface protein called PD-1, essentially putting the brakes on their ability to attack tumor cells. This is the same pathway that modern immunotherapy drugs target, which underscores how significant the effect is.
Why These Risks Compound Over a Career
What makes nursing uniquely dangerous isn’t any single exposure. It’s the combination. A nurse working night shifts in an oncology unit is simultaneously experiencing circadian disruption, handling carcinogenic drugs, and enduring high psychological stress. A nurse in a cardiac cath lab may face radiation exposure layered on top of rotating shifts and emotional strain. These exposures don’t just add up; they interact. Suppressed melatonin impairs DNA repair at the same time that chemotherapy drug traces are damaging DNA. A weakened immune system from chronic stress is less able to catch the abnormal cells that result.
Many of these risks also share a long latency period. Cancers linked to occupational exposures often don’t appear for 10 to 20 years, which makes it difficult for individual nurses to connect their diagnosis to their work. It also means that safety improvements adopted today won’t show their effects in cancer statistics for a generation. The nurses being diagnosed now were exposed under older protocols with fewer protections, and their cumulative burden of night shifts, drug exposure, and stress may span decades of a career already behind them.